Bibliografía del artículo
1. Romero R, Dey SK, Fisher SJ. Preterm labor: One syndrome, many causes. Science 345(6198):760-5, 2014. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.1251816.
2. Blencowe H, Cousens S, Chou D, Oestergaard M, Say L, Moller A, et al. Born too soon: The global epidemiology of 15 million preterm births. 10(Suppl 1):1-14, 2013.
3. March of dimes PMNCH save the children WHO. Born too soon: The Global Action Report on Preterm Birth. Geneva; 2012.
4. Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes. Societal Costs of Preterm Birth. In: Behrman, RE Butler A, editor. Preterm Birth: Causes, Consequences and Prevention [Internet]. Washington (DC): National Academies Press (US); 2007. Available from: http://www.ncbi.nlm.nih.gov/books/NBK11358/.
5. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. The Lancet 75-84, 2008.
6. Levine LD, Sammel MD, Hirshberg A, Elovitz MA, Srinivas SK. Does stage of labor at time of cesarean delivery affect risk of subsequent preterm birth? Am J Obstet Gynecol [Internet]. Elsevier Inc. 212(3):360.e1-360;.e7, 2007. Available from: http://dx.doi.org/10.1016/j.ajog.2014.09.035.
7. National Institute for Health and Care Excellence. Preterm labour and birth; NICE guideline NG25 [Internet]. 2015. Available from: nice.org.uk/guidance/ng25.
8. Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med United States 325(10):669-74, 1991.
9. Hezelgrave NL, Abbott DS, Radford SK, Seed PT, Girling JC, Filmer J, et al. Quantitative fetal fibronectin at 18 weeks of gestation to predict preterm birth in asymptomatic high-risk women. Obstet Gynecol [Internet]. 127(2):255-63, 2016. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006250-201602000-00011.
10. Abbott DS, Hezelgrave NL, Seed PT, Norman JE, David AL, Bennett PR, et al. Quantitative fetal fibronectin to predict preterm birth in asymptomatic women at high risk. Obstet Gynecol [Internet] 125(5):1168-76, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25932845.
11. Abbott DS, Radford SK, Seed PT, Tribe RM, Shennan AH. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol [Internet]. Elsevier Inc. 208(2):122.e1-122;.e6, 2013. Available from: http://dx.doi.org/10.1016/j.ajog.2012.10.890.
12. Bruijn M, Vis J, Wilms F, Oudijk M, Kwee A, Porath M, et al. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women. BJOG An Int J Obstet Gynaecol [Internet] 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26667313.
13. Kurtzman J, Chandiramani M, Briley A, Poston L, Das A, Shennan A. Quantitative fetal fibronectin screening in asymptomatic high-risk patients and the spectrum of risk for recurrent preterm delivery. Am J Obstet Gynecol [Internet] Mosby, Inc. 200(3):263.e1-263;.e6, 2009. Available from: http://dx.doi.org/10.1016/j.ajog.2009.01.018.
14. Grimes-Dennis J, Berghella V. Cervical length and prediction of preterm delivery. Curr Opin Obstet Gynecol England 19(2):191-5, 2007.
15. Kleinrouweler CE, Cheong-See FM, Collins GS, Kwee A, Thangaratinam S, Khan KS, et al. Prognostic models in obstetrics: Available, but far from applicable. Am J Obstet Gynecol Elsevier, 2015.
16. Defranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: Is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol [Internet]. Elsevier Inc. 208(3):233.e1-233;.e6, 2013. Available from: http://dx.doi.org/10.1016/j.ajog.2012.12.015.
17. Kuhrt K, Seed P, Smout E, Hezelgrave N, Shennan AH. The development and validation of a new tool to predict spontaneous preterm birth in high-risk women using quantitative fetal fibronectin and cervical length. BJOG An Int J Obstet Gynaecol [Internet] 120:14-5, 2015. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L71135636\nhttp://dx.doi.org/10.1111/1471-0528.12333\nhttp://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=14700328&id=doi:10.1111/1471-0528.12333&atitle=The development and validation.
18. Kuhrt K, Hezelgrave N, Foster C, Seed PT, Shennan AH. Development and validation of a predictive tool for spontaneous preterm birth, incorporating quantitative fetal fibronectin, in symptomatic women. Ultrasound Obstet Gynecol [Internet] 2015. Available from: http://doi.wiley.com/10.1002/uog.14894.
19. Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane database Syst Rev England 4:CD008991, 2012.
20. Suhag A, Reina J, Sanapo L, Martinelli P, Saccone G, Simonazzi G, et al. Prior ultrasound-indicated cerclage: comparison of cervical length screening or history-indicated cerclage in the next pregnancy. Obstet Gynecol United States 126(5):962-8, 2015.
21. Song JE, Lee KY, Son GH. Prediction of outcome for transabdominal cerclage in women with cervical insufficiency. Biomed Res Int United States 2015:985764, 2015.
22. Carter J, Chandirimani M, Seed P, Shennan AH. MAVRIC: Multicentre Abdominal vs Vaginal Randomised Investigation of Cerclage. BJOG An Int J Obstet Gynaecol 122:1-7, 2015.
23. Romero R. Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment. Ultrasound Obstet Gynecol [Internet]. John Wiley & Sons, Ltd.; 30(5):675-86, 2007. Available from: http://dx.doi.org/10.1002/uog.5174.
24. Romero R, Nicolaides K, Conde-Agudelo A, Tabor A, Brien JMO, Cetingoz E, et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. YMOB [Internet] Elsevier Inc. 206(2):124.e1-124;.e19, 2012. Available from: http://dx.doi.org/10.1016/j.ajog.2011.12.003.
25. Norman JE, Marlow N, Messow CM, Shennan A, Bennett PR, Thornton S, et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet [Internet]. Norman et al. Open Access article distributed under the terms of CC BY 6736(16):1-11, 2016. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673616003500.
26. Goya M, Pratcorona L, Merced C, Rodó C, Valle L, Romero A, et al. Cervical pessary in pregnant women with a short cervix (PECEP): An open-label randomised controlled trial. Lancet 379(9828):1800-6, 2012.
27. Hui SYA, Chor CM, Lau TK, Lao TT, Leung TY. Cerclage pessary for preventing preterm birth in women with a singleton pregnancy and a short cervix at 20 to 24 weeks: a randomized controlled trial. Amer J Perinatol 30(04):283-8, 2013.
28. Nicolaides KH, Syngelaki A, Poon LC, Picciarelli G, Tul N, Zamprakou A, et al. A randomized trial of a cervical pessary to prevent preterm singleton birth. N Engl J Med [Internet]. Massachusetts Medical Society 374(11):1044-52, 2016. Available from: http://dx.doi.org/10.1056/NEJMoa1511014.
29. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database Syst Rev [Internet]. (3):CD004454, 2006. Available from: http://www.epistemonikos.org/es/documents/de5c709b6d4a2316afe1dbee20d6d214ac3d2bf8\nhttp://www.ncbi.nlm.nih.gov/pubmed/16856047.
30. Freeman CI, Hezelgrave NL, Shennan AH. Antenatal steroids for fetal lung maturity: Time to target more frequent doses to fewer women? Obstet Med [Internet]. 8(4):172-6, 2015. Available from: http://obm.sagepub.com/lookup/doi/10.1177/1753495X15601772.
31. Kelly BA, Lewandowski AJ, Worton SA, Davis EF, Lazdam M, Francis J, et al. Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism. Pediatrics. United States 129(5):e1282-90, 2012.
32. Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita ATN, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med [Internet] 160204050010006, 2016. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa1516783.
33. Crowther CA, McKinlay CJ, Middleton P, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane database Syst Rev [Internet] (6):CD003935, 2011. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4170912&tool=pmcentrez&rendertype=abstract.
34. World Health Organisation. WHO recommendations on interventions to improve preterm birth outcomes. Geneva, 2015.
35. Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trial. Am J Obstet Gynecol 177(1):13-8, 1997.
36. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane database Syst Rev [Internet] (1):CD004661, 2009. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19160238.
37. Doyle L, Anderson P, Haslam R, Lee K, Crowther C. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo. JAMA [Internet] 312(11):1105-13, 2014.
38. Manuck TA, Herrera CA, Korgenski EK, Jackson M, Stoddard GJ, Porter TF, et al. Tocolysis for women with early spontaneous preterm labor and advanced cervical dilation. Obstet Gynecol 126(5):954-61, 2015.